0001727316-18-000001.txt : 20180109 0001727316-18-000001.hdr.sgml : 20180109 20180109130022 ACCESSION NUMBER: 0001727316-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180109 DATE AS OF CHANGE: 20180109 EFFECTIVENESS DATE: 20180109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ST Phi Therapeutics, Inc. CENTRAL INDEX KEY: 0001727316 IRS NUMBER: 821758264 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-302739 FILM NUMBER: 18518521 BUSINESS ADDRESS: STREET 1: STARTUP HALL, BOX 354625 STREET 2: 1100 NE CAMPUS PARKWAY, SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98195 BUSINESS PHONE: 206-518-1538 MAIL ADDRESS: STREET 1: STARTUP HALL, BOX 354625 STREET 2: 1100 NE CAMPUS PARKWAY, SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98195 D 1 primary_doc.xml X0708 D LIVE 0001727316 ST Phi Therapeutics, Inc. STARTUP HALL, BOX 354625 1100 NE CAMPUS PARKWAY, SUITE 200 SEATTLE WA WASHINGTON 98195 206-518-1538 DELAWARE None None Corporation true 2017 Lingfeng Liu Startup Hall, Box 354625 1100 NE Campus Parkway, Suite 200 Seattle WA WASHINGTON 98195 Executive Officer Director Xiaobin Guo Startup Hall, Box 354625 1100 NE Campus Parkway, Suite 200 Seattle WA WASHINGTON 98195 Executive Officer Director Biotechnology Decline to Disclose 06b false 2018-01-01 false true false 0 500000 500000 0 false 1 0 0 0 false ST Phi Therapeutics, Inc. Lingfeng Liu Lingfeng Liu President 2018-01-08